Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
222.7 CHF
0.77%
Updated:
Apr 29, 2024
Roche Holding AG
Interest Income Expense
|
Roche Holding AG
Interest Income Expense Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Interest Income Expense
-CHf893m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
6%
|
|
|
Novartis AG
SIX:NOVN
|
Interest Income Expense
-$497m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-114%
|
CAGR 10-Years
-19%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Interest Income Expense
-$90k
|
CAGR 3-Years
53%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Interest Income Expense
-$103m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Interest Income Expense?
Interest Income Expense
-893m
CHF
-893m
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Interest Income Expense amounts to -893m CHF.
What is Roche Holding AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
6%
6%
Over the last year, the Interest Income Expense growth was 8%. The average annual Interest Income Expense growth rates for Roche Holding AG have been -26% over the past three years , -16% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
